Seems news has sunk in and the market aint buying it yet for at least a long time . Have you seen Ashers Remuneration and expenses ! 42 billion shares in Issue , 100 -1 consolidation required at least
Initial clinical data in the AVA6103 program anticipated in late H2 2026.
ยท Further AVA6000 clinical data from the Phase 1a and 1b cohorts expected be released during BIO International this week (June 22-25, 2026) and further analyses at a medical congress in Q3 2026.
ยท Payload selection and clinical candidate selection in AVA6207 program expected in H2 2026.
ยท Continuing discussions with multiple parties on potential partnering of first, second and third generation assets.
@ wyndrum "because rr, i routinely say i don't know whats going on"
if you don't know what's going on and obviously have a million unanswered questions then why keep posting the same repetive ****e day in day out . just leave it and wait , it will go one way or the other simple as that
@wynbore i see you clocked on early this morning , still trying to fathom out why you are actually here to be honest especially if there are better things than AVA6K out there